Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice

Vaccine

Volumn 21, Issue 21-22, 2003, Pages 2720-2729

  Chew, Joon Lin ^a   Wolfowicz, Claudia Betina ^a   Mao, Hai Quan ^b,c,d   Leong, Kam W ^b,d   Chua, Kaw Yan ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Johns Hopkins Singapore   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chitosan nanoparticles; Der p 1; Oral

Indexed keywords

CHITOSAN; DER P 1 VACCINE; DNA VACCINE; HOUSE DUST ALLERGEN; NANOPARTICLE; PLASMID DNA; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; GENE CONSTRUCT; GENETIC CODE; IMMUNE RESPONSE; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; PRIORITY JOURNAL;

EID: 0038513487     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00228-7     Document Type: Article

References (48)

1. Wolff J.A., Malone R.W., Williams P.et al. Direct gene transfer into mouse muscle in vivo. Science. 247(4949 (Part 1)):1990;1465-1468.
2. Hsu C.H., Chua K.Y., Tao M.H., Huang S.K., Hsieh K.H. Inhibition of specific IgE response in vivo by allergen-gene transfer. Int. Immunol. 8(9):1996;1405-1411.
3. Hsu C.H., Chua K.Y., Tao M.H.et al. Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunisation. Nat. Med. 2(5):1996;540-544.
4. Huang S.K., Chua K.Y., Hsieh K.H. Allergen gene transfer. Curr. Opin. Immunol. 9(6):1997;800-804.
5. Singh M., Vajdy M., Gardner J., Briones M., O'Hagan D. Mucosal immunisation with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity. Vaccine. 20(3-4):2001;594-602.
6. Roy K., Mao H.Q., Huang S.K., Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5(4):1999;387-391.
7. Challacombe S.J., Rahman D., Jeffery H., Davis S.S., O'Hagan D.T. Enhanced secretory IgA and systemic IgG antibody responses after oral immunisation with biodegradable microparticles containing antigen. Immunology. 76(1):1992;164-168.
8. Bowersock T.L., HogenEsch H., Suckow M.et al. Oral vaccination of animals with antigens encapsulated in alginate microspheres. Vaccine. 17(13-14):1999;1804-1811.
9. Chen S.C., Jones D.H., Fynan E.F.et al. Protective immunity induced by oral immunisation with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72(7):1998;5757-5761.
10. Herrmann J.E., Chen S.C., Jones D.H.et al. Immune responses and protection obtained by oral immunisation with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles. Virology. 259(1):1999;148-153.
11. Jones D.H., Corris S., McDonald S., Clegg J.C., Farrar G.H. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 15(8):1997;814-817.
12. Jones D.H., Clegg J.C., Farrar G.H. Oral delivery of micro-encapsulated DNA vaccines. Dev. Biol. Stand. 92:1998;149-155.
13. Kaneko H., Bednarek I., Wierzbicki A.et al. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein. Virology. 267(1):2000;8-16.
14. Mathiowitz E., Jacob J.S., Jong Y.S.et al. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 386(6623):1997;410-414.
15. O'Hagan D.T., McGee J.P., Holmgren J.et al. Biodegradable microparticles for oral immunisation. Vaccine. 11(2):1993;149-154.
16. Borchard G. Chitosans for gene delivery. Adv. Drug Deliv. Rev. 52(2):2001;145-150.
17. Singla A.K., Chawla M. Chitosan: some pharmaceutical and biological aspects - an update. J. Pharm. Pharmacol. 53(8):2001;1047-1067.
18. van der Lubben I.M., Verhoef J.C., Borchard G., Junginger H.E. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur. J. Pharm. Sci. 14(3):2001;201-207.
19. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15(9):1998;1326-1331.
20. Ranaldi G., Marigliano I., Vespignani I., Perozzi G., Sambuy Y. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line(1). J. Nutr. Biochem. 13(3):2002;157-167.
21. Mao H.Q., Roy K., Troung L.et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J. Control. Rel. 70(3):2001;399-421.
22. Richardson S.C., Kolbe H.V., Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 178(2):1999;231-243.
23. van der Lubben I.M., Konings F.A., Borchard G., Verhoef J.C., Junginger H.E. In vivo uptake of chitosan microparticles by murine Peyer's patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. J. Drug Target. 9(1):2001;39-47.
24. van der Lubben I.M., Verhoef J.C., van Aelst A.C., Borchard G., Junginger H.E. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials. 22(7):2001;687-694.
25. Chua K.Y., Stewart G.A., Thomas W.R.et al. Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. Homology with cysteine proteases. J. Exp. Med. 167(1):1988;175-182.
26. Chua K.Y., Kehal P.K., Thomas W.R., Vaughan P.R., Macreadie I.G. High-frequency binding of IgE to the Der p allergen expressed in yeast. J. Allergy Clin. Immunol. 89(1 (Part 1)):1992;95-102.
27. Greene W.K., Cyster J.G., Chua K.Y., O'Brien R.M., Thomas W.R. IgE and IgG binding of peptides expressed from fragments of cDNA encoding the major house dust mite allergen Der p I. J. Immunol. 147(11):1991;3768-3773.
28. Collins S.P., Ball G., Vonarx E.et al. Absence of continuous epitopes in the house dust mite major allergens Der p I from Dermatophagoides pteronyssinus and Der f I from Dermatophagoides farinae. Clin. Exp. Allergy. 26(1):1996;36-42.
29. Duchateau J., Michils A., Michel O., Baras L. Mite allergy is associated with a specific profile of IgG epitopes recognized on antigen p 1 of Dermatophagoides pteronyssinus. Clin. Exp. Allergy. 27(3):1997;296-305.
30. Jarnicki A.G., Thomas W.R. Stimulatory and inhibitory epitopes in the T cell responses of mice to Der p 1. Clin. Exp. Allergy. 32(6):2002;942-950.
31. O'Brien R.M., Thomas W.R., Tait B.D. An immunogenetic analysis of T-cell reactive regions on the major allergen from the house dust mite, Der p I, with recombinant truncated fragments. J. Allergy Clin. Immunol. 93(3):1994;628-634.
32. Yssel H., Johnson K.E., Schneider P.V.et al. T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones. J. Immunol. 148(3):1992;738-745.
33. Wolfowicz C.B., Huangfu T.Q., Chua K.Y. Expression and immunogenicity of the major house dust mite allergen Der p 1 following DNA immunization. Vaccine. 21:2002;1195-1204.
34. O'Brien R.M., Thomas W.R., Tait B.D. An immunogenetic analysis of T-cell reactive regions on the major allergen from the house dust mite, Der p I, with recombinant truncated fragments. J. Allergy Clin. Immunol. 93(3):1994;628-634.
35. Greene W.K., Cyster J.G., Chua K.Y., O'Brien R.M., Thomas W.R. IgE and IgG binding of peptides expressed from fragments of cDNA encoding the major house dust mite allergen Der p I. J. Immunol. 147(11):1991;3768-3773.
36. Thomas W.R., Stewart G.A., Simpson R.J.et al. Cloning and expression of DNA coding for the major house dust mite allergen Der p 1 in Escherichia coli. Int. Arch. Allergy Appl. Immunol. 85(1):1988;127-129.
37. Thomas W.R., Chua K.Y., Smith W.A. Molecular polymorphisms of house dust mite allergens. Exp. Appl. Acarol. 16(1-2):1992;153-164.
38. Etchart N., Buckland R., Liu M.A., Wild T.F., Kaiserlian D. Class I-restricted CTL induction by mucosal immunisation with naked DNA encoding measles virus haemagglutinin. J. Gen. Virol. 78(Part 7):1997;1577-1580.
39. Takeuchi H., Yamamoto H., Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 47(1):2001;39-54.
40. Filipovic-Grcic J., Skalko-Basnet N., Jalsenjak I. Mucoadhesive chitosan-coated liposomes: characteristics and stability. J. Microencapsul. 18(1):2001;3-12.
41. Ferrari F., Rossi S., Bonferoni M.C., Caramella C., Karlsen J. Characterization of rheological and mucoadhesive properties of three grades of chitosan hydrochloride. Farmaco. 52(6-7):1997;493-497.
42. Beier R., Gebert A. Kinetics of particle uptake in the domes of Peyer's patches. Am. J. Physiol. 275(Part 1):1998;G130-G137.
43. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J. Control. Rel. 11(1-3):1990;205-214.
44. Hershberg R.M., Mayer L.F. Antigen processing and presentation by intestinal epithelial cells - polarity and complexity. Immunol. Today. 21(3):2000;123-128.
45. Dodane V., Amin Khan M., Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 182(1):1999;21-32.
46. Wikingsson L., Sjoholm I. Polyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in mice. Vaccine. 20(27-28):2002;3355.
47. Eo S.K., Gierynska M., Kamar A.A., Rouse B.T. Prime-boost immunisation with DNA vaccine: mucosal route of administration changes the rules. J. Immunol. 166(9):2001;5473-5479.
48. Wierzbicki A., Kiszka I., Kaneko H.et al. Immunisation strategies to augment oral vaccination with DNA and viral vectors expressing HIV envelope glycoprotein. Vaccine. 20(9-10):2002;1295-1307.